Impact of tobacco smoking on the patient's outcome after (chemo)radiotherapy for anal cancer-Reference-Cited by-同舟云学术

Impact of tobacco smoking on the patient's outcome after (chemo)radiotherapy for anal cancer

Published:2020-12 Issue: Volume:141 Page:143-151
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Lerman Jacques,Hennequin Christophe,Etienney Isabelle,Abramowitz Laurent,Goujon Gael,Gornet Jean-Marc,Guillerm Sophie,Aparicio Thomas,Valverde Alain,Cattan Pierre,Quéro Laurent

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference27 articles.

1. Anal cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Glynne-Jones;Ann Oncol,2014

2. Changing patterns of anal canal carcinoma in the United States;Nelson;J Clin Oncol,2013

3. Epidemiological and economic burden of potentially HPV-related cancers in France;Abramowitz;PloS One,2018

4. Human papillomavirus genotype distribution in anal cancer in France: the EDiTH V study;Abramowitz;Int J Canc,2011

5. The increasing incidence of anal cancer: can it be explained by trends in risk groups?;van der Zee;Neth J Med,2013

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tobacco smoking influences the side effects of radiation therapy-managed patients with various malignancies: A systematic review;Journal of Medical Imaging and Radiation Sciences;2024-12

2. Relationship between anal cancer recurrence and cigarette smoking;World Journal of Clinical Oncology;2023-07-24

3. Outcomes of preoperative chemoradiotherapy after complete smoking cessation followed by total mesorectal excision with selective lateral pelvic lymph node dissection for locally advanced low rectal cancer;2023-02-02

4. Anal carcinoma diagnosed over a 20‐year period in a Spanish tertiary center: A retrospective analysis;JEADV Clinical Practice;2022-12-26

5. The prognostic impact of PD-L1 and CD8 expression in anal cancer patients treated with chemoradiotherapy;Frontiers in Oncology;2022-10-07